‘Elites’ Need To Understand Clinical Development Remains Necessary For Drug Discovery, Woodcock Says
Executive Summary
US FDA’s principal deputy commissioner continues to preach clinical trial reform, saying stakeholders must remember that understanding a molecule does not equate to understanding its impact on the body.